3.750% Convertible Senior Notes due 2026Indenture • September 17th, 2019 • Heska Corp • In vitro & in vivo diagnostic substances • New York
INDENTURE, dated as of September 17, 2019, between HESKA CORPORATION, a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
